A novel form of cell therapy may help patients who are critically ill with acute respiratory distress syndrome (ARDS) brought on by severe COVID-19, according to a study.
A study suggested that a new type of cell therapy may improve the prognosis of patients critically unwell with acute respiratory distress syndrome (ARDS) caused by severe COVID-19.
Philadelphia (Pennsylvania) [US], April 9 (ANI): Researchers have discovered a new type of cell that resides deep within human lungs and may play a key role in human lung diseases.